Molecular Dissection of Mitogillin Reveals That the Fungal Ribotoxins Are a Family of Natural Genetically Engineered Ribonucleases*

Richard KaoDagger and Julian Davies

From the Department of Microbiology and Immunology, The University of British Columbia, 6174 University Blvd., Vancouver, British Columbia V6T 1Z3, Canada

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Mitogillin and the related fungal ribotoxins are highly specific ribonucleases which inactivate the ribosome enzymatically by cleaving the 23-28 S RNA of the large ribosomal subunit at a single phosphodiester bond. The site of cleavage occurs between G4325 and A4326 (rat ribosome numbering) which are present in one of the most conserved sequences (the alpha -sarcin loop) among the large subunit ribosomal RNAs of all living species. Amino acid sequence comparison of ribotoxins and guanyl/purine ribonucleases have identified domains or residues likely involved in ribonucleolytic activity or cleavage specificity. Fifteen deletion mutants (each 4 to 8 amino acid deletions) in motifs of mitogillin showing little amino acid sequence homology with guanyl/purine ribonucleases were constructed by site-directed mutagenesis. Analyses of the purified mutant proteins identified those regions in fungal ribotoxins contributing to ribosome targeting and modulating the catalytic activity of the toxin; some of the identified motifs are homologous to sequences in ribosomal proteins and elongation factors. This mutational study of mitogillin together with the recently published x-ray structure of restrictocin (a close relative of mitogillin) supports the hypothesis that the specific cleavage properties of ribotoxins are the result of natural genetic engineering in which the ribosomal targeting elements of ribosome-associated proteins were inserted into nonessential regions of T1-like ribonucleases.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Mitogillin and the related Aspergillus fungal ribotoxins restrictocin and alpha -sarcin, are small basic proteins of ~17 kDa (kilodaltons). Mitogillin differs from restrictocin by only 1 amino acid and has 86% amino acid sequence identity with alpha -sarcin (1-4). The fungal ribotoxins are a family of highly specific ribonucleases which inactivate the ribosome by cleavage of the 23-28 S RNA of the large ribosomal subunit (5) at a single phosphodiester bond. The site of cleavage occurs between G4325 and A4326 (rat ribosome numbering) in a 14-base sequence (the alpha -sarcin loop) found in the large subunit ribosomal RNAs (rRNAs)1 of all living species. This single cleavage completely abolishes the capability of ribosomes to carry out protein synthesis (6-8) by inhibiting elongation factor 1-dependent binding of aminoacyl-tRNA and GTP-dependent binding of elongation factor 2 to ribosomes. Mitogillin-like ribotoxins are among the most potent inhibitors of translation so far identified and studies have been carried out to investigate their potential as anti-tumor agents or components of immunotoxins (9-14).

The recognition elements of the structure of the alpha -sarcin loop in 28 S rRNA have been studied extensively (15, 16) and G4319 was proposed to be the identity element for alpha -sarcin (17). However, very little is known about the ribosome-targeting elements of the protein toxins. Mitogillin and related ribotoxins are known to share amino acid sequence similarity with T1-like ribonucleases (8) and alpha -sarcin has been shown to behave as a cyclizing ribonuclease like many other ribonucleases (18), but their property to interact specifically with the ribosome and cause a single ribonucleolytic cleavage in the large subunit rRNA is unique. Previous studies indicated that the similarities and differences detected in amino acid sequence comparison of ribotoxins and a large family of other guanyl/purine ribonucleases may represent domains or residues key to ribonucleolytic activity and specificity (19, 20). The presence of these "extra" protein domains (some of which are similar to sequences in ribosome-associated proteins) in fungal ribotoxins led to the hypothesis that fungal ribotoxins are a family of naturally engineered toxins with ribosomal targeting elements acquired from different ribosome-associated proteins (19). The prediction that the fungal ribotoxins are T1-like ribonucleases with additional protein domains extended from the catalytic core of the RNase is confirmed by the crystal structure of restrictocin determined by x-ray analysis (21) and the three-dimensional structure of alpha -sarcin in solution determined by NMR (22). These structural analyses also support the proposal that the ribosomal protein-like region Lys106-Lys113 is the major ribosomal recognition element in mitogillin (19). In the present study we report the characterization and properties of 15 deletion mutants (4 to 8 amino acid deletions) in motifs of mitogillin having little amino acid sequence homology with guanyl/purine ribonucleases and the identification of elements in mitogillin (and related ribotoxins) contributing to its specific cleavage of ribosomes.

    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Bacterial Strains and Plasmids-- An Escherichia coli host (derivative of W3110) and the plasmid pING3522 were used for the production of mitogillin and mutant mitogillin proteins. pING3522 is an inducible secretion vector with the expression of the inserted gene under the control of the Salmonella typhimurium araB promoter; the secretion of recombinant proteins through the cytoplasmic membrane is directed by the Erwinia carotovora pelB leader sequence (14).

Design and Construction of Deletion Mutants-- Polymerase chain reaction (PCR)-mediated site-directed mutagenesis was employed to construct deletion mutants in three regions (Gln8-Thr43, Asp56-Lys88, and Lys106-Lys113) of mitogillin (Fig. 1A). Nucleotide sequences of oligonucleotides used to construct mutants are shown in Table I. PCR-mediated site-specific mutagenesis is described in Fig. 1B. RK-01 (forward "universal" primer) was mixed with a reverse mutagenic oligo and RK-02 (reverse universal primer) was mixed with a forward mutagenic oligo; PCR was carried out directly on single E. coli colonies (containing pING3522 plasmid) in two separate 100-µl reactions (50 mM KCl, 10 mM Tris-Cl, pH 8.3, 1.5 mM MgCl2, 100 pmol of each primer oligonucleotide, and 200 µM of each dNTP). The tubes were heated at 94 °C for 5 min before the addition of 2.5 units of Taq polymerase, overlaid with paraffin oil and 30 cycles of PCR carried out (94 °C for 1 min, 55 °C for 2 min, and 72 °C for 3 min). The PCR products were electrophoresed on a 1% agarose gel and purified using QIAquick gel extraction kit (QIAGEN). Purified PCR products were mixed and the volume was brought to 100 µl with 50 mM KCl, 10 mM Tris-Cl, pH 8.3, 1.5 mM MgCl2, 200 µM of each dNTP, and 2.5 units of Taq polymerase, and incubated at 94 °C for 1 min, 55 °C for 2 min, and 72 °C for 10 min to achieve the 3' extension of the mixed PCR products. PCR amplification of the mutagenized mitogillin gene was then accomplished by adding 100 pmol of each of oligomers RK-01 and RK-02, and 2.5 units of Taq polymerase, overlaid with paraffin oil and reincubated at 94 °C for 1 min, 55 °C for 2 min, and 72 °C for 3 min, for 30 cycles. The final PCR product was purified by electrophoresis followed by QIAquick extraction. The purified fragment was ligated to PstI-HindIII-digested pING3522 and transformed into E. coli. The nucleotide sequence of each mutant was verified. Production of mutant mitogillin proteins was detected by SDS-PAGE (0.1% SDS, 15% polyacrylamide) of the induced culture supernatants followed by Western blotting using rabbit antisera raised against mitogillin.


View larger version (30K):
[in this window]
[in a new window]
 
Fig. 1.   Mutagenesis of mitogillin. A, sites of deletion are indicated. Shown also are the secondary structures of mitogillin: beta 1, beta -sheet 1; L1, loop 1; beta 2, beta -sheet 2; H1, alpha -helix 1; L2, loop 2; beta 3, beta -sheet 3; L3, loop 3; H2, alpha -helix 2; beta 4, beta -sheet 4; L4, loop 4; beta 5, beta -sheet 5; L5, loop 5; beta 6, beta -sheet 6; L6, loop 6; beta 7, beta -sheet 7. B, schematic representation of the PCR-mediated site-specific deletion of the mitogillin gene. Shown are the PstI/HindIII restriction enzyme sites and the relative positions of various PCR primers. Site of deletion is indicated by an *.

                              
View this table:
[in this window]
[in a new window]
 
Table I
Oligonucleotides used for site-directed mutagenesis of the mitogillin gene
Oligonucleotides RK-01 and RK-02 were "universal" primers used for site-directed mutagenesis and DNA sequencing. RK-01 binds upstream of the mitogillin gene near the araC gene, and RK-02 binds near the tet gene in the vector region of pING3522. For detailed information on DNA sequences of plasmid pING3522 and the mitogillin gene, see Better et al. (14).

Production and Purification of Mutant Mitogillins-- E. coli harboring pING3522-derived plasmids containing the mutagenized mitogillin gene were grown at 37 °C to A600 = 0.4 in Tryptone broth (containing 10 µg of tetracycline/ml), induced by the addition of 0.1% L-arabinose (Sigma) and grown for 18 h. Secreted proteins were purified by cation exchange chromatography followed by size-exclusion chromatography as described previously (20) except that 50 mM sodium phosphate buffer, pH 7.2, was used for cation exchange chromatography.

Assay for Nonspecific Ribonucleolytic Activity-- Ribonucleolytic activity of ribonuclease T1, mitogillin, and mutant mitogillins against poly(I) homopolymer (Sigma) was examined by methods described previously (20). 200 µM poly(I) homopolymer substrate was used in all cleavage assays. In initial rate experiments, 50 nM of each protein was used and the extent of poly(I) homopolymers hydrolysis was less than 10% of the total and MicroCon-100 concentrators (molecular cut-off = 300 nucleotides for single-stranded RNA; purchased from Amicon) were used to separate cleavage products from poly(I) homopolymers. Ribonucleolytic activity against MS-2 phage RNA was determined by incubating RNA (400 ng) with 300 nM purified protein in 10 µl of reaction buffer (15 mM Tris-HCl, pH 7.6, 15 mM NaCl, 50 mM KCl, 2.5 mM EDTA). The reaction was incubated at 37 °C for 30 min, stopped by the addition of 1.0 µl of 5% SDS, and separated by electrophoresis (1.2% agarose) as described previously (19); the gel was stained with ethidium bromide to visualize the degradation of the RNA substrate. An activity staining assay (zymogram electrophoresis) described by Blank et al. (23) was employed to monitor the presence of contaminating ribonucleases. Briefly, SDS-PAGE of 150 ng of each of the mutant mitogillins was performed under nonreducing condition on a 0.1% SDS, 15% polyacrylamide gel containing 0.3 mg of poly(I) substrate. The gel was treated as described by Blank et al. (23) and incubated in 100 mM Tris-HCl, pH 7.4, at 37 °C for 1 h, stained with 0.2% toluidine blue for 10 min at room temperature and washed extensively with distilled water for 1 h. RNase activity was indicated by the appearance of a clear zone on a dark blue background.

Specific Cleavage of Rabbit Ribosomes and Synthetic alpha -Sarcin Loop RNA-- Specific cleavage of eukaryotic ribosomes was done in reaction mixtures with 10 µl of untreated rabbit reticulocyte lysate (Promega), 600 nM toxin protein, 15 mM Tris-HCl, pH 7.6, 15 mM NaCl, 50 mM KCl, and 2.5 mM EDTA, incubated at 37 °C for 15 min. Extracted RNA was separated by electrophoresis (1.5% agarose) and RNA species visualized by staining with ethidium bromide. The specific ribonucleolytic activity of the toxin derivatives was followed by the appearance of the alpha -fragment, a ~400 nucleotide RNA species on the gel. A RNA oligonucleotide (a 35-mer) that mimics the alpha -sarcin domain of the eukaryotic large subunit rRNA was prepared with synthetic DNA templates, T7 RNA polymerase, and the four nucleotide triphosphates and purified using denaturing polyacrylamide gel electrophoresis (24, 25). 1.0 µM synthetic RNA 35-mer was combined with 600 nM mitogillin or mutant mitogillins for a total volume of 6.0 µl in 10 mM Tris-HCl, pH 7.4, and incubated at 37 °C for 15 min. The reaction was stopped by the addition of 4.0 µl of deionized formamide and heating at 95 °C for 3 min. Cleavage products were separated by denaturing polyacrylamide gel electrophoresis and the gel stained with SYBR-GOLD nucleic acid stain (Molecular Probes).

    RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Mutant Construction and Protein Purification-- Fifteen deletion mutants of mitogillin in regions predicted to be functional elements inserted into a T1 ribonuclease core structure were constructed. The mutant genes were completely sequenced to confirm the nature of the deletions; no other alterations were detected. Production of mutant proteins on growth in liquid culture was detected from 10 clones (Table II) by Western blotting with a rabbit antiserum (data not shown). SDS-PAGE followed by silver staining of the purified proteins confirmed their purity (Fig. 4A).

                              
View this table:
[in this window]
[in a new window]
 
Table II
Production of mutant mitogillin proteins
Production was detected by SDS-PAGE of induced culture supernatants followed by Western blotting using rabbit anti-mitogillin antisera.

Nonspecific Ribonucleolytic Activity-- RNase activity of mitogillin and all 10 mutant proteins was detected when poly(I) homopolymers (Fig. 2) or MS-2 phage RNA (Fig. 3) were used as substrates. The comparison between the ribonuclease activities of mutant and wild-type mitogillin using poly(I) homopolymer is shown in Fig. 2; initial rates of reaction are tabulated in Table III. The data indicates that deleting Lys13-Lys16, Lys16-Asp19, or Lys20-Leu23 increased the RNase activity; Lys28-Ser31, Arg77-Gln83, or Lys106-Lys113 decreased the RNase activity, while the deletion of Asp56-Lys60, Gly59-Ile62, Lys63-Ile68, or Asn84-Lys88 had little effect as judged by the initial rates of ribonucleolytic reaction. Results obtained from the zymogram electrophoresis assay (Fig. 4B) eliminate the possibility of the presence of contaminating ribonucleases in the preparations.


View larger version (25K):
[in this window]
[in a new window]
 
Fig. 2.   Nonspecific ribonucleolytic activity of mitogillin and its mutants on poly(I) substrate. Results were plotted as percent of poly(I) degradation versus time when 3 µM mitogillin or a mutant protein was used.


View larger version (38K):
[in this window]
[in a new window]
 
Fig. 3.   MS-2 phage RNA degradation assay. The ribonucleolytic activity of the mutant mitogillin proteins was assayed by examining the extent of degradation of MS-2 phage RNA. Lane 1, mitogillin; lane 2, no toxin; lane 3, Delta Lys13-Lys16 mutant; lane 4, Delta Lys16-Asp19 mutant; lane 5, Delta Lys20-Leu23 mutant; lane 6, Delta Lys28-Ser31 mutant; lane 7, Delta Asn56-Lys60 mutant; lane 8, Delta Gly59-Ile62 mutant; lane 9, Delta Lys63-Ile68 mutant; lane 10, Delta Arg77-Gln83 mutant; lane 11, Delta Asn84-Lys88 mutant; and lane 12, Delta Lys106-Lys113 mutant.

                              
View this table:
[in this window]
[in a new window]
 
Table III
Comparison of the ribonucleolytic activity (initial rate of cleavage) of mitogillin, mutant mitogillins, and ribonuclease T1 on poly(I) homopolymer


View larger version (30K):
[in this window]
[in a new window]
 
Fig. 4.   A, SDS-PAGE of mutant mitogillins. 1 µg of each mutant protein was run on a 0.1% SDS-15% polyacrylamide gel under nonreducing conditions. Presence of protein was detected by silver staining procedures. B, zymogram electrophoresis. SDS-PAGE of 150 ng of each of the mutant mitogillin proteins was performed under nonreducing condition on a 0.1% SDS-15% polyacrylamide gel containing 0.3 mg of poly(I) substrate (Sigma). RNase activity was indicated by the appearance of clearing band on the poly(I) containing polyacrylamide gel stained with toluidine blue. Lane 1, mitogillin; lane 2, Delta Lys13-Lys16 mutant; lane 3, Delta Lys16-Asp19 mutant; lane 4, Delta Lys20-Leu23 mutant; lane 5, Delta Lys28-Ser31 mutant; lane 6, Delta Asp56-Lys60 mutant; lane 7, Delta Gly59-Ile62 mutant; lane 8, Delta Lys63-Ile68 mutant; lane 9, Delta Arg77-Gln83 mutant; lane 10, Delta Asn84-Lys88 mutant; and lane 11, Delta Lys106-Lys113 mutant. Shown also are the positions of molecular markers in kilodaltons.

Specific Ribonucleolytic Activity-- On treatment of rabbit reticulocyte lysates with purified mitogillin or the deletion variants, a distinctive alpha -fragment band was detected in all samples except the Delta Lys106-Lys113 deletion mutant (Fig. 5A). Extensive degradation of 28 S RNA in ribosomes by Lys13-Leu23 deletion mutants suggests that this region in the fungal ribotoxin is involved in modulating the activity and specific recognition of the cleavage site in the ribosome. Results obtained from assays using synthetic alpha -sarcin loop (a 35-mer) as substrate showed that deletions in regions Lys13-Lys16, Lys16-Asp19, or Lys20-Leu23 gave rise to mitogillin variants with elevated ribonucleolytic activity while deletion of Lys106-Lys113 created a mutant which fails to recognize and cleave the alpha -sarcin loop (Fig. 5B).


View larger version (101K):
[in this window]
[in a new window]
 
Fig. 5.   A, specific ribonucleolytic activity (in vitro alpha -fragment release) of mitogillin and its variants. Positions of 28 S rRNA, 18 S rRNA, and alpha -fragment are indicated. B, synthetic alpha -sarcin loop cleavage assay. Positions of 35-mer, 21-mer, and 14-mer are also indicated. Details of the assay conditions are described under "Experimental Procedures." Lane 1, mitogillin; lane 2, no toxin; lane 3, Delta Lys13-Lys16 mutant; lane 4, Delta Lys16-Asp19 mutant; lane 5, Delta Lys20-Leu23 mutant; lane 6, Delta Lys28-Ser31 mutant; lane 7, Delta Asp56-Lys60 mutant; lane 8, Delta Gly59-Ile62 mutant; lane 9, Delta Lys63-Ile68 mutant; lane 10, Delta Arg77-Gln83 mutant; lane 11, Delta Asn84-Lys88 mutant; and lane 12, Delta Lys106-Lys113 mutant.


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Structural comparison between the three-dimensional structures of restrictocin (99% identity with mitogillin) and T1 ribonuclease reveals strong structural similarities with certain domains in the fungal ribotoxins absent from the T1 ribonucleases; the most obvious differences are the beta 1-loop 1-beta 2 region, the loop 3 region, and the loop 4 region of restrictocin (Fig. 6). It has been postulated that these domains are "inserted" elements contributing to the specific targeted, cytotoxicity of this class of proteins; preliminary studies on the loop 4 region indicated that this region indeed is the major ribosome-targeting elements of mitogillin (19). We have generated deletions (4-8 amino acid residues) in those regions of mitogillin proposed to be inserted elements. Deletions were preferred over amino acid substitutions for this analysis in order to identify domains responsible for targeting mitogillin to the ribosome and examine the influence of these inserted regions on the general properties of the fungal ribotoxin. Ten of the 15 deletion mutants produce biologically active proteins using the E. coli expression system. It is interesting to note that the five non-expressible mutant mitogillin proteins have deletions located near or extending into elements such as disulfide bridge-forming cysteine residues, proline residues, or helixes, which are likely to be susceptible to host protease activity. The majority of the deletions obtained retain the catalytic activity of the ribotoxin which supports the proposal that these domains have roles in ribotoxin function distinct from the RNase activity.


View larger version (26K):
[in this window]
[in a new window]
 
Fig. 6.   Structural comparison of restrictocin and ribonuclease T1. Secondary structures of the proteins are labeled: beta 1, beta -sheet 1; L1, loop 1; beta 2, beta -sheet 2; H1, alpha -helix 1; L2, loop 2; beta 3, beta -sheet 3; L3, loop 3; H2, alpha -helix 2; beta 4, beta -sheet 4; L4, loop 4; beta 5, beta -sheet 5; L5, loop 5; beta 6, beta -sheet 6; L6, loop 6; beta 7, beta -sheet 7. Positions of the catalytically important residues His49, Glu95, Arg120, and His136 of restrictocin and the corresponding residues His40, Glu58, Arg77, and His92 of ribonuclease T1 are also indicated. Noted is the absence of beta 1-loop 1-beta 2, loop 3, and loop 4 domains of mitogillin in ribonuclease T1. The coordinates of restrictocin and ribonuclease T1 are taken from Protein data bank files 1AQZ (21) and 1RNT (28), respectively.

Deletions in loop 4 and in beta 1-loop 1-beta 2 regions generate mutants with interesting properties in terms of their ribonucleolytic activities. We have shown that the octapeptide Lys106 to Lys113 in the loop 4 region has sequence similarity to various ribosome-associated proteins (19) and that the heptapeptide Thr14 to Lys20 in the beta 1-loop 1-beta 2 region is strongly related to motifs in various elongation factors (Table IV). Although the significance of these relationships has yet to be examined, it is noteworthy that the Delta Lys106-Lys113 mutant (previously termed Delta 2 mutant in Ref. 19) has lost the ability to recognize and cleave the alpha -sarcin loop (19) (Fig. 5, A and B, this study), and that the ribonucleolytic activity of the deletion mutants in the beta 1-loop 1-beta 2 region is greatly elevated (20-30-fold higher than that of wild-type mitogillin, Table III). The alpha -sarcin loop/restrictocin docking model of Yang and Moffat (21) suggests that the loop 4 region of mitogillin is in close proximity to the 28 S rRNA identity element (G4319) of the fungal ribotoxin; our results support the conclusion that elements in the loop 4 domain interact with the "bulged" G4319 in the alpha -sarcin loop to promote specific recognition and cleavage of the substrate.

                              
View this table:
[in this window]
[in a new window]
 
Table IV
Homologous motifs found in mitogillin and in translation elongation factors

However, the beta 1-loop 1-beta 2 region of mitogillin is relatively distant from the catalytic center of the nuclease; the role of this domain in attenuating the catalytic activity of the toxin is intriguing. We propose that this is the result of hydrogen bond formation between amino acid residues in beta 1 and beta 2, and residues in beta 6 in which the catalytic residue His136 is situated (Fig. 7). It is possible that the beta 1-loop 1-beta 2 domain attenuates the catalytic activity of the toxin by keeping the catalytic residue His136 in a configuration suboptimal for nucleolytic activity through hydrogen bonding with beta 6. Upon binding to the ribosome, the interactions between loop 4 and the alpha -sarcin loop trigger a conformational change in the protein which disrupts the interactions between the beta 1-loop 1-beta 2 domain and beta 6, so positioning the catalytic residue His136 in a optimal environment for cleavage of phosphodiester bond of the RNA substrate. Evidence in favor of this interpretation comes from the analysis of a N7A mutant of mitogillin (which presumably eliminates the hydrogen bonding between Asn7 and His136) which shows greatly elevated ribonuclease activity (Table III). The detailed biochemical properties of the N7A mutant are currently under investigation. Our interpretation also agrees with the findings of Takeda et al. (27) which suggest that the fungal ribotoxins bind to two sites in the RNA substrate; one through the bulged G4319 and the other around the GAGA tetraloop cleavage site. An RNA oligomer substrate with the deleted bulged G is unsusceptible to alpha -sarcin cleavage but becomes a strong noncompetitive inhibitor of the wild-type RNA molecule (with the bulged G), which suggests that the association between the RNA recognition element (bulged G4319) and the first substrate-binding site in mitogillin (elements in loop 4 of the protein) may trigger a conformational change in the active site of the ribotoxin which permits the efficient cleavage of the GAGA tetraloop. Shapiro (26) demonstrated that the enzymatic potency and specificity of human angiogenin are partly modulated by hydrogen bonding between two distant amino acid residues (Thr44 and Thr80) that inability to form the hydrogen bond (made possible by a T80A mutation) increases the ribonucleolytic activity of angiogenin 11-15-fold (26). This raises the possibility that substrate-specific ribonucleases other than fungal ribotoxins may also modulate their specific activity by similar mechanisms.


View larger version (26K):
[in this window]
[in a new window]
 
Fig. 7.   Hydrogen-bonding between beta -loop 1-beta and beta -loop 6-beta domains of restrictocin. Loop 1 residues 11-16 are fully exposed to solvent and are consequently missing in the atomic model. Hydrogen bonds are denoted by dashed lines. Amino acid residues not relevant in forming hydrogen bonds were omitted for clarity.

Deletions in region Asp56 to Lys88 (loop 3) of mitogillin do not appear to interfere with the ribonucleolytic activity or the specificity of mitogillin. The dramatic decrease in RNase activity in Delta Arg77-Gln83 may be due to the deletion of a catalytically important residue(s) or a change in the structure of the toxin affecting its catalytic activity. The latter interpretation is more likely since the active site of mitogillin does not indicate the involvement of any residues in region Arg77-Gln83 for catalysis (20). However, these residues being adjacent to Cys75 which forms a disulfide bond with Cys5 in mitogillin and deletion of Arg77-Gln83 would presumably induce a change in the microenvironment of the active site of mitogillin and, as a result, reduce RNA cleavage activity. Based on available information we cannot define further the functions of loop 3 of mitogillin. Yang and Moffat (21) suggest that this region may influence mitogillin/cell surface receptor recognition or translocation of the toxin through the lipid bilayer of the cell; mutants constructed in this region would be good candidates to elucidate the functions of this extra loop of the fungal ribotoxins.

In conclusion, we have described the production and properties of 10 deletion mutants of mitogillin, predicated on the hypothesis that motifs showing little amino acid sequence homology with guanyl/purine ribonucleases are functional domains inserted into T1-like ribonucleases through natural genetic engineering. Characterization of the enzymatic properties of the mutant proteins suggests that elements in loop 4 region of mitogillin are involved in the specific recognition of the toxin to the ribosome and elements in beta 1-loop 1-beta 2 region involved in modulating the catalytic activity of the toxin. Our studies also suggest that loop 3 of mitogillin may be involved in functions other than targeting mitogillin to the ribosome. It is evident that these additional elements, which appear to have been engineered naturally into T1-like ribonucleases, are not required for RNase activity but have functions specific to cytotoxic activity. The availability of these mutants will aid in further investigation of the biochemical and/or physiological roles of ribotoxin function. An interesting question is whether it will be possible to insert such targeting motifs into other protein sequences to generate other types of ribosome-specific toxins.

    ACKNOWLEDGEMENTS

We thank Dr. M. Better for providing E. coli W3110, plasmid pING3522, purified mitogillin, and rabbit anti-mitogillin antibody. We also thank Drs. S. B. delCardayre and V. Webb for helpful discussions.

    FOOTNOTES

* This work was supported by the Natural Sciences and Engineering Research Council.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Dagger To whom reprint requests should be addressed. E-mail: kao{at}davies.microbiology.ubc.ca.

    ABBREVIATIONS

The abbreviations used are: rRNA, ribosomal ribonucleic acids; PCR, polymerase chain reaction; PAGE, polyacrylamide gel electrophoresis.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
  1. Fernandez-Luna, J. L., Lopez-Otin, C., Soriano, F., and Mendez, E. (1985) Biochemistry 24, 861-867[Medline] [Order article via Infotrieve]
  2. Lopez-Otin, C., Barber, D., Fernandez-Luna, J. L., Soriano, F., and Mendez, E. (1984) Eur. J. Biochem. 143, 621-634[Abstract]
  3. Rodriguez, R., Lopez-Otin, C., Barber, D., Fernandez-Luna, J. L., Gonzalez, G., and Mendez, E. (1982) Biochem. Biophys. Res. Commun. 108, 315-321[Medline] [Order article via Infotrieve]
  4. Sacco, G., Drickamer, K., and Wool, I. G. (1983) J. Biol. Chem. 258, 5811-5818[Abstract/Free Full Text]
  5. Schindler, D. G., and Davies, J. E. (1977) Nucleic Acids Res. 4, 1097-1110[Abstract]
  6. Endo, Y., and Wool, I. G. (1982) J. Biol. Chem. 257, 9054-9060[Abstract/Free Full Text]
  7. Fando, J. L., Alaba, I., Escarmis, C., Fernandez-Luna, J. L., Mendez, E., and Salinas, M. (1985) Eur. J. Biochem. 149, 29-34[Abstract]
  8. Lamy, B., Davies, J., and Schindler, D. (1992) in Genetically Engineered Toxins (Frankel, A. E., ed), pp. 237-257, Marcel Dekker, New York
  9. Olson, B. H., and Goerner, G. L. (1965) Appl. Microbiol. 13, 314-321
  10. Olson, B. H., Jennings, J. C., Roga, V., Junek, A. J., and Schuurmans, D. M. (1965) Appl. Microbiol. 13, 322-326
  11. Orlandi, R., Canevari, S., Conde, F. P., Leoni, F., Mezzanzanica, D., Ripamonti, M., and Colnaghi, M. I. (1988) Cancer Immunol. Immunother. 26, 114-120[Medline] [Order article via Infotrieve]
  12. Conde, F. P., Orlandi, R., Canvevari, S., Mezzanzanica, D., Ripamonti, M., Munoz, S. M., Jorge, P., and Colnaghi, M. I. (1989) Eur. J. Biochem. 178, 795-802[Abstract]
  13. Wawrzynczak, E. J., Henry, R. V., Cumber, A. J., Parnell, G. D., Derbyshire, E. J., and Ulbrich, N. (1991) Eur. J. Biochem. 196, 203-209[Abstract]
  14. Better, M., Bernhard, S. L., Lei, S. P., Fishwild, D. M., and Carroll, S. F. (1992) J. Biol. Chem. 267, 16712-16718[Abstract/Free Full Text]
  15. Gluck, A., Endo, Y., and Wool, I. G. (1992) J. Mol. Biol. 226, 411-424[Medline] [Order article via Infotrieve]
  16. Gluck, A., Endo, Y., and Wool, I. G. (1994) Nucleic Acids Res. 22, 321-324[Abstract]
  17. Gluck, A., and Wool, I. G. (1996) J. Mol. Biol. 256, 838-848[CrossRef][Medline] [Order article via Infotrieve]
  18. Lacadena, J., Martinez del Pozo, A., Lacadena, V., Martinez-Ruiz, A., Mancheno, J. M., Onaderra, M., and Gavilanes, J. G. (1998) FEBS Lett. 424, 46-48[CrossRef][Medline] [Order article via Infotrieve]
  19. Kao, R., and Davies, J. (1995) Biochem. Cell Biol. 73, 1151-1159[Medline] [Order article via Infotrieve]
  20. Kao, R., Shea, J. E., Davies, J., and Holden, D. W. (1998) Mol. Microbiol. 29, 1019-1027[CrossRef][Medline] [Order article via Infotrieve]
  21. Yang, X., and Moffat, K. (1996) Structure 4, 837-852[Medline] [Order article via Infotrieve]
  22. Campos-Olivas, R., Bruix, M., Santoro, J., Martinez del Pozo, A., Lacadena, J., Gavilanes, J. G., and Rico, M. (1996) FEBS Lett. 399, 163-165[CrossRef][Medline] [Order article via Infotrieve]
  23. Blank, A., Sugiyama, R. H., and Dekker, C. A. (1982) Anal. Biochem. 120, 267-275[Medline] [Order article via Infotrieve]
  24. Endo, Y., Chan, Y. L., Lin, A., Tsurugi, K., and Wool, I. G. (1988) J. Biol. Chem. 263, 7917-7920[Abstract/Free Full Text]
  25. Milligan, J. F., Groebe, D. R., Witherell, G. W., and Uhlenbeck, O. C. (1987) Nucleic Acids Res. 15, 8783-8798[Abstract]
  26. Shapiro, R. (1998) Biochemistry 37, 6847-6856[CrossRef][Medline] [Order article via Infotrieve]
  27. Takeda, E., Bi, X., Yoshinari, S., and Endo, Y. (1997) Nucleic Acids Symp. Ser. 37, 131-132[Medline] [Order article via Infotrieve]
  28. Arni, R., Heinemann, U., Tokuoka, R., and Saenger, W. (1988) J. Biol. Chem. 263, 15358-15368[Abstract/Free Full Text]


Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.